Thoma Bravo has agreed to acquire a majority stake in MedeAnalytics Inc, a provider of financial performance analytics for the healthcare market. No financial terms were disclosed. As a result of the transaction, MedeAnalytics’ previous backers Bain Capital Integral Investors LLC and Emergence Capital Partners will retain their minority stakes.
San Francisco – September 2, 2015 – Thoma Bravo, LLC, a leading private equity investment firm, announced today that it has entered into an agreement to make a majority investment in MedeAnalytics, Inc., a provider of cloud-based financial performance analytics for the healthcare industry. Prior investors Bain Capital Integral Investors LLC and Emergence Capital Partners will remain minority shareholders. Financial details were not disclosed.
“MedeAnalytics represents an outstanding investment opportunity in the healthcare data analytics sector,” said Scott Crabill, managing partner at Thoma Bravo. “Andy Hurd and the MedeAnalytics team have built a market-leading business with a well-deserved reputation for product innovation. We look forward to partnering with management to continue growing the company organically and through strategic acquisitions.”
“We are very excited to work with Thoma Bravo,” said Andy Hurd, chief executive officer at MedeAnalytics. “It was important for us to partner with an investment firm that will support our team as we build on the considerable momentum we have created in the dynamic healthcare analytics space. Given its expertise in our sector, Thoma Bravo is the ideal partner to help us continue to grow and succeed.”
MedeAnalytics provides evidence-based insights that help healthcare providers leverage the vast amounts of data available to deliver cost-effective care and promote a healthier population. Through its analytics platform, MedeAnalytics delivers the intelligence that healthcare organizations require to improve their financial health.
MedeAnalytics’ cloud-based tools are used by over 1500 healthcare organizations globally. Analytics have played an important and growing role in the healthcare industry, as reigning in costs and providing faster payment turnaround times for insurers and providers is essential to their success.
“Our partnership with MedeAnalytics is an incredible opportunity to invest in a market leader in a mission critical sector,” said Arvindh Kumar, principal at Thoma Bravo. “Healthcare analytics is a growing market, one that plays a significant role in the healthcare industry that is only growing more important with each passing day.”
About Thoma Bravo, LLC
Thoma Bravo is a leading private equity investment firm building on a 30+ year history of providing equity and strategic support to experienced management teams and growing companies. The firm seeks to create value by collaborating with company management to improve business operations and provide capital to support growth initiatives. Thoma Bravo invests with a particular focus on application and infrastructure software and technology enabled services. The firm currently manages a series of private equity funds representing more than $8.5 billion of equity commitments. For more information, visit www.thomabravo.com.
MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare – how to use the immense amount of patient data collected along the care continuum to deliver cost-effective care and promote a healthier population. Its analytics platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics’ cloud-based tools have been used to uncover business insights for over 1500 healthcare organizations across the United States and United Kingdom. The company has also been named one of Modern Healthcare’s top 100 Best Places to Work in Healthcare for 2014 and 2015. For more information, visit www.medeanalytics.com.